Related references
Note: Only part of the references are listed.MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives
Safieh Ebrahimi et al.
CELLULAR ONCOLOGY (2019)
The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression
Xiaoming Zhong et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer
Huan-Xi Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance
Helen Aggelou et al.
VIRCHOWS ARCHIV (2018)
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis
Noemi Eiro et al.
CELLULAR ONCOLOGY (2018)
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
Gustav van Niekerk et al.
CELLULAR ONCOLOGY (2018)
Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance
Pritish Nilendu et al.
CELLULAR ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68
Xue Wang et al.
MOLECULAR CANCER (2018)
Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting with PRKDC via activating the AKT pathway
Changcan Li et al.
CELL DEATH & DISEASE (2018)
Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-β induced epithelial mesenchymal transition via Src/ANXA2/STAT3
Murilo R. Rocha et al.
SCIENTIFIC REPORTS (2018)
Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy
Chih-Yang Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers
Zhifeng Zhang et al.
PLOS ONE (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
The HMGB1-CXCL12 Complex Promotes Inflammatory Cell Infiltration in Uveitogenic T Cell-Induced Chronic Experimental Autoimmune Uveitis
Juan Yun et al.
FRONTIERS IN IMMUNOLOGY (2017)
LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression
Qing Liao et al.
BRITISH JOURNAL OF CANCER (2017)
Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1
Sikander Sharma et al.
CELL AND TISSUE RESEARCH (2016)
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar et al.
IMMUNITY (2016)
Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway
Jingwen Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells
Zhiwei Wang et al.
MOLECULAR MEDICINE REPORTS (2016)
Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells
Karthik Subramanian Chandrasekaran et al.
TUMOR BIOLOGY (2016)
The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
Xiaoli Zhang et al.
ONCOTARGETS AND THERAPY (2016)
The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration
Georg Gdynia et al.
NATURE COMMUNICATIONS (2016)
Secreted HMGB1 from Wnt activated intestinal cells is required to maintain a crypt progenitor phenotype
Karen R. Reed et al.
ONCOTARGET (2016)
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis
Lucia Cottonea et al.
ONCOIMMUNOLOGY (2016)
HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway
Weijun Liu et al.
CANCER BIOLOGY & THERAPY (2015)
High-mobility group Box 1: A novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma
Lingyin Zhu et al.
CANCER LETTERS (2015)
Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma
Lingyin Zhu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer
Zhengxiang Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
High-mobility group box 1 protein activating nuclear factor-B to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer
Yan Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2015)
High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule
Huan Yang et al.
MOLECULAR MEDICINE (2015)
5-Fluorouracil causes leukocytes attraction in the peritoneal cavity by activating autophagy and HMGB1 release in colon carcinoma cells
Lucia Cottone et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The HMGB1 protein sensitizes colon carcinoma cells to cell death triggered by pro-apoptotic agents
Chengcheng Christine Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
α-Actinin-4 Enhances Colorectal Cancer Cell Invasion by Suppressing Focal Adhesion Maturation
Miki Fukumoto et al.
PLOS ONE (2015)
Redox Modulation of HMGB1-Related Signaling
Christina Janko et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Cancer Usurps Skeletal Muscle as an Energy Repository
Yi Luo et al.
CANCER RESEARCH (2014)
Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer
Hiroto Kikuchi et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps
N. Maugeri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
A Systematic Nomenclature for the Redox States of High Mobility Group Box (HMGB) Proteins
Daniel J. Antoine et al.
MOLECULAR MEDICINE (2014)
The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
Cem Sezer
MEDICAL SCIENCE MONITOR (2014)
HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection
Wei Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy
Yi Luo et al.
EUROPEAN JOURNAL OF CANCER (2013)
Progastrin-Induced Secretion of Insulin-Like Growth Factor 2 From Colonic Myofibroblasts Stimulates Colonic Epithelial Proliferation in Mice
Carrie A. Duckworth et al.
GASTROENTEROLOGY (2013)
p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release
He-Xin Yan et al.
JOURNAL OF HEPATOLOGY (2013)
RAGE and TLRs: Relatives, friends or neighbours?
Zaridatul Aini Ibrahim et al.
MOLECULAR IMMUNOLOGY (2013)
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
J. R. van Beijnum et al.
ONCOGENE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Chromosomal aneuploidy affects the global proteome equilibrium of colorectal cancer cells
Timo Gemoll et al.
ANALYTICAL CELLULAR PATHOLOGY (2013)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential
Benjamin Frey et al.
JOURNAL OF IMMUNOTOXICOLOGY (2012)
Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon
Ferenc Sipos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
Eric Tartour et al.
CANCER AND METASTASIS REVIEWS (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Pathogen Recognition by the Innate Immune System
Himanshu Kumar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor Immunity
Zuqiang Liu et al.
JOURNAL OF IMMUNOLOGY (2011)
HMGB proteins and transcriptional regulation
Tetsuya Ueda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
High-mobility group box 1 and cancer
Daolin Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Redox metabolism and malignancy
Christina L. Grek et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer
Yi Luo et al.
EUROPEAN JOURNAL OF CANCER (2010)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Analysis of Nuclear High Mobility Group Box 1 (HMGB1)-Binding Proteins in Colon Cancer Cells: Clustering with Proteins Involved in Secretion and Extranuclear Function
Hanna Lee et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Tumor metastasis and the lymphatic vasculature
Jonathan P. Sleeman et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability
R. Seth et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Eosinophils Oxidize Damage-Associated Molecular Pattern Molecules Derived from Stressed Cells
Ramin Lotfi et al.
JOURNAL OF IMMUNOLOGY (2009)
Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers
Hyun Ju Kang et al.
LABORATORY INVESTIGATION (2009)
Suppression of Dendritic Cells by HMGB1 Is Associated with Lymph Node Metastasis of Human Colon Cancer
Akiko Kusume et al.
PATHOBIOLOGY (2009)
G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
Farbod Shojaei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release
Tegest Aychek et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Apoptosis: controlled demolition at the cellular level
Rebecca C. Taylor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer
Shin Maeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Involvement of RNA helicases p68 and p72 in colon cancer
Sook Shin et al.
CANCER RESEARCH (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature
Judy R. van Beijnum et al.
BLOOD (2006)
Leukocytes, inflammation, and angiogenesis in cancer:: fatal attractions
Curzio Ruegg
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas
K Völp et al.
GUT (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
E-cadherin regulates the association between β-catenin and actinin-4
Y Hayashida et al.
CANCER RESEARCH (2005)
Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages
H Kuniyasu et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
H Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration
OJ Sansom et al.
GENES & DEVELOPMENT (2004)
Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer
H Kuniyasu et al.
PATHOBIOLOGY (2004)
Differential effects between amphoterin and advanced glycation end products on colon cancer cells
H Kuniyasu et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Structural basis for the proinflammatory cytokine activity of high mobility group box 1
JH Li et al.
MOLECULAR MEDICINE (2003)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
The role of tumor lymphangiogenesis in metastatic spread
SA Stacker et al.
FASEB JOURNAL (2002)
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
K Akagi et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
